Detalles de la búsqueda
1.
Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients.
Ann Hematol
; 102(2): 261-270, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459182
2.
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry.
J Cell Mol Med
; 26(9): 2520-2528, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355397
3.
Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting.
Haematologica
; 108(4): 1158-1162, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35924578
4.
Longitudinal changes in LIC and other parameters in patients receiving different chelation regimens: Data from LICNET.
Eur J Haematol
; 100(2): 124-130, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29094403
5.
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Br J Haematol
; 176(1): 124-130, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27748513
6.
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.
Am J Hematol
; 97(2): E75-E78, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861054
7.
Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
Eur J Haematol
; 97(4): 361-70, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26818147
8.
Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.
Am J Hematol
; 90(7): 634-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25809173
9.
Management of the Sickle Cell Trait: An Opinion by Expert Panel Members.
J Clin Med
; 12(10)2023 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37240547
10.
The use of hydroxyurea in the real life of MIOT network: an observational study.
Expert Opin Drug Saf
; 21(11): 1433-1440, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35435090
11.
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.
Front Med (Lausanne)
; 9: 832154, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35372393
12.
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.
Hemoglobin
; 35(3): 206-16, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21599433
13.
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
Br J Haematol
; 145(2): 245-54, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19236376
14.
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
Orphanet J Rare Dis
; 14(1): 120, 2019 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31146777
15.
Review and Recommendations on Management of Adult Female Thalassemia Patients with Hypogonadism based on Literature Review and Experience of ICET-A Network Specialists.
Mediterr J Hematol Infect Dis
; 9(1): e2017001, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28101307
Resultados
1 -
15
de 15
1
Próxima >
>>